We are live on ! Find out more
PCM

Pinz Capital Management Portfolio holdings

AUM $55.2M
1-Year Est. Return 15.31%
This Fund
S&P 500
This Quarter Est. Return
+34.49%
1 Year Est. Return
-15.31%
3 Year Est. Return
+198.79%
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
Cap. Flow
+$259M
Cap. Flow %
94.92%
Top 10 Hldgs %
14.6%
Holding
313
New
313
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.35%
2 Technology 17.29%
3 Consumer Discretionary 10.58%
4 Industrials 10.56%
5 Real Estate 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
76
Gilead Sciences
GILD
$165B
$2.27M 0.83%
+35,000
New +$2.28M
SCHW
77
Charles Schwab
SCHW
$186B
$2.27M 0.83%
+47,800
New +$2.11M
INCY icon
78
Incyte
INCY
$24.3B
$2.27M 0.83%
+26,000
New +$2.22M
AZO icon
79
AutoZone
AZO
$49.9B
$2.26M 0.83%
+1,900
New +$2.19M
HOLX
80
DELISTED
Hologic
HOLX
$2.25M 0.82%
+43,100
New +$2.15M
VRSK icon
81
Verisk Analytics
VRSK
$25.1B
$2.24M 0.82%
+15,000
New +$2.22M
VRAY
82
DELISTED
ViewRay, Inc.
VRAY
$2.24M 0.82%
+530,000
New +$1.71M
MO icon
83
Altria Group
MO
$114B
$2.24M 0.82%
+44,800
New +$2.11M
ROKU icon
84
Roku
ROKU
$22.6B
$2.22M 0.81%
+16,600
New +$2.28M
XYZ
85
Block Inc
XYZ
$47.4B
$2.22M 0.81%
+35,420
New +$2.26M
UAL icon
86
United Airlines
UAL
$41.8B
$2.2M 0.81%
+25,000
New +$2.24M
NFLX icon
87
Netflix
NFLX
$309B
$2.2M 0.81%
+68,000
New +$2.02M
XP icon
88
XP
XP
$8.46B
$2.17M 0.79%
+56,250
New +$2.11M
CLVS
89
DELISTED
Clovis Oncology, Inc.
CLVS
$2.17M 0.79%
+207,800
New +$1.51M
TTEC icon
90
TTEC Holdings
TTEC
$124M
$2.15M 0.79%
+54,300
New +$2.38M
AXNX
91
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.1M 0.77%
+75,800
New +$1.81M
SAFE
92
DELISTED
Safehold Inc.
SAFE
$2.05M 0.75%
+50,800
New +$1.86M
EVOP
93
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2.04M 0.75%
+77,300
New +$2.13M
IMMU
94
DELISTED
Immunomedics Inc
IMMU
$2.03M 0.74%
+96,100
New +$1.7M
MDGL icon
95
Madrigal Pharmaceuticals
MDGL
$11.9B
$1.7M 0.62%
+18,695
New +$1.81M
CRSP icon
96
CRISPR Therapeutics
CRSP
$5.18B
$1.55M 0.57%
+25,500
New +$1.39M
ARDX icon
97
Ardelyx
ARDX
$1.02B
$1.53M 0.56%
+203,500
New +$1.24M
DUK icon
98
Duke Energy
DUK
$97.2B
$1.26M 0.46%
+13,800
New +$1.27M
ASMB icon
99
Assembly Biosciences
ASMB
$525M
$1.25M 0.46%
+5,082
New +$936K
KRTX
100
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.18M 0.43%
+15,660
New +$686K

Similar funds

Pinz Capital Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Pinz Capital Management, which disclosed 313 positions worth $273M. Its ten largest holdings account for 15% of the portfolio.

Its largest position is PennyMac Mortgage Investment: 193,800 shares worth $4.32M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Technology and Consumer Discretionary.

  • Pinz Capital Management's largest Q4 2019 buy was PennyMac Mortgage Investment: 193,800 shares worth $4.32M.
  • Pinz Capital Management's ten largest holdings make up 15% of its $273M portfolio in Q4 2019.
  • Pinz Capital Management disclosed 313 positions in Q4 2019, its first 13F filing on record.

Based on Pinz Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.